Search

humanized SMART Anti-IL-12 Antibody

IL-12 is a cytokine that may have considerable potential as a target in the therapy of autoimmune diseases.

RUTI® Vaccine

Much like the BCG vaccine, the RUTI® vaccine is also being tested as a prophylactic for SARS-CoV2.

Affitope AD01

Affitope AD01 is an investigational drug developed for immunization to treat Alzheimer's Disease. AD01 is a short peptide (7 amino acids in length) that induces Aß-targeting antibodies, therefore lowering Aß aggregates.

Sulfametrole

Aducanumab

[A235668,A235720] Clinical trials showed a 23% relative difference between the experimental and placebo groups as determined by CDR; however, this is equivalent to an absolute difference of 0.4/18.

Gemtuzumab ozogamicin

Marketing approval of gemtuzumab ozogamicin was granted on May 17, 2000 by FDA as a treatment for patients with CD33-positive AML in first relapse who are 60 years of age or older and who are not considered

Bamlanivimab

Bamlanivimab (LY-CoV555, also known as LY3819253), is a synthetic monoclonal antibody (mAb) derived from one of the first blood samples in the United States from a patient who recovered from COVID-19.

Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine

As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.

Distigmine

Distigmine is available in several countries as a treatment of underactive detrusor and voiding dysfunction in the urinary tract where the active ingredient is distigmine bromide.

Bupranolol

Bupranolol is a non-selective beta blocker with potency similar to propanolol. It does not have intrinsic sympathomimetic activity (ISA), but does have strong membrane stabilizing activity.